Myelodysplastic Syndromes: Updates and Nuances

Kim Hien T. Dao

Research output: Contribution to journalReview articlepeer-review

9 Scopus citations


Myelodysplastic syndrome (MDS) is a heterogeneous, clonal stem cell disorder of the blood and marrow typically diagnosed based on the presence of persistent cytopenia(s), dysplastic cells, and genetic markers. Common issues that arise in the clinical management include difficulty confirming MDS diagnosis, lack of a standard approach with novel agents in MDS, and few prospective long-term, randomized controlled MDS clinical studies to guide allogeneic blood and marrow transplant. With the recent genetic characterization of MDS, certain aspects of these issues will be better addressed by integrating genetic data into clinical study design and clinical practice.

Original languageEnglish (US)
Pages (from-to)333-350
Number of pages18
JournalMedical Clinics of North America
Issue number2
StatePublished - Mar 1 2017


  • Anemia
  • Azacitidine
  • Blood and marrow transplant
  • Myelodysplastic syndrome
  • Therapy-related myelodysplastic syndrome

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Myelodysplastic Syndromes: Updates and Nuances'. Together they form a unique fingerprint.

Cite this